About this Journal Submit a Manuscript Table of Contents
Journal of Skin Cancer
Volume 2012 (2012), Article ID 707260, 4 pages
http://dx.doi.org/10.1155/2012/707260
Review Article

HOX Gene Aberrant Expression in Skin Melanoma: A Review

Department of Dermatopathology, Liège University Hospital, 4000 Liège, Belgium

Received 3 July 2012; Revised 4 September 2012; Accepted 4 September 2012

Academic Editor: Giuseppe Argenziano

Copyright © 2012 Gérald E. Piérard and Claudine Piérard-Franchimont. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. U. Leiter and C. Garbe, “Epidemiology of melanoma and nonmelanoma skin cancer—the role of sunlight,” Advances in Experimental Medicine and Biology, vol. 624, pp. 89–103, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Quatresooz and G. E. Piérard, “Malignant melanoma: from cell kinetics to micrometastases,” American Journal of Clinical Dermatology, vol. 12, no. 2, pp. 77–86, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. G. E. Piérard, “Cell proliferation in malignant melanoma: relationship with neoplastic progression,” International Scholarly Research Network, vol. 2012, Article ID 828146, 12 pages, 2012. View at Publisher · View at Google Scholar
  4. J. A. Carlson, J. S. Ross, A. Slominski et al., “Molecular diagnostics in melanoma,” Journal of the American Academy of Dermatology, vol. 52, no. 5, pp. 743–775, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. L. A. Fecher, S. D. Cummings, M. J. Keefe, and R. M. Alani, “Toward a molecular classification of melanoma,” Journal of Clinical Oncology, vol. 25, no. 12, pp. 1606–1620, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. M. A. Reginster, C. Piérard-Franchimont, G. E. Piérard, and P. Quatresooz, “Molecular dermatopathology in malignant melanoma,” Dermatology Research and Practice, vol. 2012, Article ID 684032, 6 pages, 2012. View at Publisher · View at Google Scholar
  7. J. Walter-Yohrling, X. Cao, M. Callahan et al., “Identification of genes expressed in malignant cells that promote invasion,” Cancer Research, vol. 63, no. 24, pp. 8939–8947, 2003. View at Scopus
  8. F. Ades and O. Metzger-Filho, “Targeting the cellular signalling: BRAF inhibition and beyond for the treatment of metastatic malignant melanoma,” Dermatology Research and Practice, vol. 2012, Article ID 259170, 2012.
  9. G. E. Piérard, F. Aubin, and P. Humbert, “Ipilimumab, a promising immunotherapy with increased overall survival in metastatic melanoma?” Dermatology Research and Practice, vol. 2012, Article ID 182157, 4 pages, 2012. View at Publisher · View at Google Scholar
  10. C. Piérard-Franchimont and G. E. Piérard, “Metastatic melanoma: some hope from ipilimumab and vemurafenib,” Revue Medicale De Liège, vol. 67, pp. 64–68, 2012.
  11. I. Yajima, M. Y. Kumasaka, N. Dinh Thang et al., “RAS/RAF/MEK/ERK and P13K/PTEN/AKT signalling in malignant melanoma progression and therapy,” Dermatology Research and Practice, vol. 2012, Article ID 354191, 2012.
  12. P. Quatresooz, C. Piérard-Franchimont, F. Noel, and G. E. Piérard, “Thigmotropism of malignant melanoma cells,” Dermatology Research and Practice, vol. 2012, Article ID 362784, 6 pages, 2012. View at Publisher · View at Google Scholar
  13. N. Claessens, G. E. Piérard, C. Piérard-Franchimont, J. E. Arrese, and P. Quatresooz, “Immunohistochemical detection of incipient melanoma micrometastases. Relationship with sentinel lymph node involvement,” Melanoma Research, vol. 15, no. 2, pp. 107–110, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Quatresooz, J. E. Arrese, C. Pierard-Franchimont, and G. E. Pierard, “Immunohistochemical aid at risk stratification of melanocytic neoplasms,” International journal of oncology, vol. 24, no. 1, pp. 211–216, 2004. View at Scopus
  15. P. Quatresooz, G. E. Piérard, C. Piérard-Franchimont, and The Mosan Study Group of Pigmented Tumors, “Molecular pathways supporting the proliferation staging of malignant melanoma,” International Journal of Molecular Medicine, vol. 24, pp. 295–301, 2009.
  16. K. L. Scott, C. Nogueira, T. P. Heffernan et al., “Proinvasion metastasis drivers in early-stage melanoma are oncogenes,” Cancer Cell, vol. 20, no. 1, pp. 92–103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Cillo, A. Faiella, M. Cantile, and E. Boncinelli, “Homeobox genes and cancer,” Experimental Cell Research, vol. 248, no. 1, pp. 1–9, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Deschamps and F. Meijlink, “Mammalian homeobox genes in normal development and neoplasia,” Critical reviews in oncogenesis, vol. 3, no. 1-2, pp. 117–173, 1992. View at Scopus
  19. F. Mavilio, “Regulation of vertebrate homeobox-containing genes by morphogens,” European Journal of Biochemistry, vol. 212, no. 2, pp. 273–288, 1993. View at Scopus
  20. M. P. Scott, “Vertebrate homeobox gene nomenclature,” Cell, vol. 71, no. 4, pp. 551–553, 1992. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Cillo, “HOX genes in human cancers,” Invasion and Metastasis, vol. 14, no. 1–6, pp. 38–49, 1994. View at Scopus
  22. K. Maeda, J. I. Hamada, Y. Takahashi et al., “Altered expressions of HOX genes in human cutaneous malignant melanoma,” International Journal of Cancer, vol. 114, no. 3, pp. 436–441, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Delval, A. Taminiau, J. Lamy et al., “The Pbx interactions motif of Hoxa1 is essential for its oncogenic activity,” PLoS One, vol. 6, Article ID e25247, 2011.
  24. K. Rhoads, G. Arderiu, A. Charboneau, S. L. Hansen, W. Hoffman, and N. Boudreau, “A role for Hox A5 in regulating angiogenesis and vascular patterning,” Lymphatic Research and Biology, vol. 3, no. 4, pp. 240–252, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Furuta, Y. Nobeyama, Y. Umebayashi, F. Otsuka, K. Kikuchi, and T. Ushijima, “Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas,” Cancer Research, vol. 66, no. 12, pp. 6080–6086, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. C. J. Ceol, Y. Houvras, J. Jane-Valbuena et al., “The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset,” Nature, vol. 471, no. 7339, pp. 513–518, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Carè, A. Silvani, E. Meccia et al., “HOXB7 constitutively activates basic fibroblast growth factor in melanomas,” Molecular and Cellular Biology, vol. 16, no. 9, pp. 4842–4851, 1996. View at Scopus
  28. S. Braig, D. W. Mueller, T. Rothhammer, and A. K. Bosserhoff, “MicroRNA miR-196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma,” Cellular and Molecular Life Sciences, vol. 67, no. 20, pp. 3535–3548, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Felicetti, L. Bottero, N. Felli et al., “Role of PLZF in melanoma progression,” Oncogene, vol. 23, no. 26, pp. 4567–4576, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Cillo, M. Cantile, R. Mortarini, P. Barba, G. Parmiani, and A. Anichini, “Differential patterns of HOX gene expression are associated with specific integrin and ICAM profiles in clonal populations isolated from a single human melanoma metastasis,” International Journal of Cancer, vol. 66, pp. 692–697, 1996.
  31. M. Cantile, G. Scognamiglio, A. Anniciello, et al., “Increased HOX C13 expression in metastatic melanoma progression,” Journal of Translational Medicine, vol. 10, no. 1, p. 91, 2012.
  32. D. W. Mueller and A. K. Bosserhoff, “MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression,” International Journal of Cancer, vol. 129, no. 5, pp. 1064–1074, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Taveira da Cruz and M. Galvonas-Jasiulionis, “miRNAs and melanoma: how are they connected?” Dermatology Research and Practice, vol. 2012, Article ID 528345, 2012.
  34. Y. Okubo, J. I. Hamada, Y. Takahashi et al., “Transduction of HOXD3-antisense into human melanoma cells results in decreased invasive and motile activities,” Clinical and Experimental Metastasis, vol. 19, no. 6, pp. 503–511, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Cantile, R. Franco, A. Tschan et al., “HOX D13 expression across 79 tumor tissue types,” International Journal of Cancer, vol. 125, no. 7, pp. 1532–1541, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. A. I. Riker, S. A. Enkemann, O. Fodstad et al., “The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis,” BMC Medical Genomics, vol. 1, p. 13, 2008.
  37. W. Bordogna, J. D. Hudson, J. Buddle, D. C. Bennett, D. H. Beach, and A. Carnero, “EMX homeobox genes regulate microphthalmia and alter melanocyte biology,” Experimental Cell Research, vol. 311, no. 1, pp. 27–38, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Morgan, P. M. Pirard, L. Shears, J. Sohal, R. Pettengell, and H. S. Pandha, “Antagonism of HOX/PBX dimer formation blocks the in vivo proliferation of melanoma,” Cancer Research, vol. 67, no. 12, pp. 5806–5813, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. F. S. Jones, G. Chalepakis, P. Gruss, and G. M. Edelman, “Activation of the cytotactin promoter by the homeobox-containing gene Evx-1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 6, pp. 2091–2095, 1992. View at Scopus
  40. F. S. Jones, E. A. Prediger, D. A. Bittner, E. M. De Robertis, and G. M. Edelman, “Cell adhesion molecules as targets for Hox genes: neural cell adhesion molecule promoter activity is modulated by cotransfection with Hox-2.5 and -2.4,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 6, pp. 2086–2090, 1992. View at Scopus
  41. F. S. Jones, B. D. Holst, O. Minowa, E. M. De Robertis, and G. M. Edelman, “Binding and transcriptional activation of the promoter for the neural cell adhesion molecule by HoxC6 (Hox-3.3),” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 14, pp. 6557–6561, 1993. View at Scopus
  42. R. S. Goomer, B. D. Holst, I. C. Wood, F. S. Jones, and G. M. Edelman, “Regulation in vitro of an L-CAM enhancer by homeobox genes HoxD9 and HNF-1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 17, pp. 7985–7989, 1994. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Halaban, B. S. Kwon, S. Ghosh, P. Delli Bovi, and A. Baird, “bFGF as an autocrine growth factor for human melanomas,” Oncogene Research, vol. 3, no. 2, pp. 177–186, 1988. View at Scopus
  44. D. Becker, C. B. Meier, and M. Herlyn, “Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor,” The EMBO Journal, vol. 8, no. 12, pp. 3685–3691, 1989. View at Scopus
  45. A. A. Seyhan, “RNAi: a potential new class of therapeutic for human genetic disease,” Human Genetics, vol. 30, pp. 1–23, 2011. View at Publisher · View at Google Scholar · View at Scopus